Search

Your search keyword '"Binkley, Michael S."' showing total 198 results

Search Constraints

Start Over You searched for: Author "Binkley, Michael S." Remove constraint Author: "Binkley, Michael S."
198 results on '"Binkley, Michael S."'

Search Results

1. Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy

2. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

4. KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

5. Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume

7. Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

8. Inferring gene expression from cell-free DNA fragmentation profiles

10. First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema

11. Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL)

13. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer

14. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors

15. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

16. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG

17. Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG

18. 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy

23. Supplementary Figures S1-S7 from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

24. Supplementary Table S1 from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

26. Abstract 5960: Identification and validation of sarcoma cellular ecosystems associated with prognosis and predictive of immunotherapy response

27. Data from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

28. Supplementary Figures 1-9 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

29. Data from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

30. Supplementary Tables S1-S7 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

31. Supplemental Methods from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

32. Supplemental Tables from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

33. Supplemental Figures from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

35. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR)

37. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

38. STK11Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer

40. Investigating and modeling positron emission tomography factors associated with large cell transformation from low‐grade lymphomas

44. The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

46. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)

48. Abstract PO-059: Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer

Catalog

Books, media, physical & digital resources